742 related articles for article (PubMed ID: 30927950)
81. Manganese-Enhanced Magnetic Resonance Imaging in Takotsubo Syndrome.
Singh T; Joshi S; Kershaw LE; Baker AH; McCann GP; Dawson DK; Dweck MR; Semple SI; Newby DE
Circulation; 2022 Dec; 146(24):1823-1835. PubMed ID: 36317524
[TBL] [Abstract][Full Text] [Related]
82. Cardiovascular Magnetic Resonance Mapping and Strain Assessment for the Diagnosis of Cardiac Involvement in Idiopathic Inflammatory Myopathy Patients With Preserved Left Ventricular Ejection Fraction.
Wang Y; Wang Q; Cao J; Li X; Lin L; Chen W; Wang YN; Jin ZY
J Thorac Imaging; 2021 Jul; 36(4):254-261. PubMed ID: 33560763
[TBL] [Abstract][Full Text] [Related]
83. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
84. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.
Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M
JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283
[TBL] [Abstract][Full Text] [Related]
85. Native Myocardial T1 as a Biomarker of Cardiac Structure in Non-Ischemic Cardiomyopathy.
Shah RV; Kato S; Roujol S; Murthy V; Bellm S; Kashem A; Basha T; Jang J; Eisman AS; Manning WJ; Nezafat R
Am J Cardiol; 2016 Jan; 117(2):282-8. PubMed ID: 26684511
[TBL] [Abstract][Full Text] [Related]
86. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values.
Mahmod M; Piechnik SK; Levelt E; Ferreira VM; Francis JM; Lewis A; Pal N; Dass S; Ashrafian H; Neubauer S; Karamitsos TD
J Cardiovasc Magn Reson; 2014 Nov; 16(1):92. PubMed ID: 25410203
[TBL] [Abstract][Full Text] [Related]
87. Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
Ridouani F; Damy T; Tacher V; Derbel H; Legou F; Sifaoui I; Audureau E; Bodez D; Rahmouni A; Deux JF
J Cardiovasc Magn Reson; 2018 Aug; 20(1):58. PubMed ID: 30115079
[TBL] [Abstract][Full Text] [Related]
88. Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis.
Briasoulis A; Lama N; Rempakos A; Theodorakakou F; Stamatelopoulos K; Dimopoulos MA; Kelekis N; Kastritis E
Curr Probl Cardiol; 2023 Apr; 48(4):101573. PubMed ID: 36586704
[TBL] [Abstract][Full Text] [Related]
89. Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis.
Luetkens JA; Homsi R; Sprinkart AM; Doerner J; Dabir D; Kuetting DL; Block W; Andrié R; Stehning C; Fimmers R; Gieseke J; Thomas DK; Schild HH; Naehle CP
Eur Heart J Cardiovasc Imaging; 2016 Feb; 17(2):154-61. PubMed ID: 26476398
[TBL] [Abstract][Full Text] [Related]
90. Myocardial Tissue Characterization in Cardiac Magnetic Resonance Studies of Patients Recovering From COVID-19: A Meta-Analysis.
Jerosch-Herold M; Rickers C; Petersen SE; Coelho-Filho OR
J Am Heart Assoc; 2023 Mar; 12(6):e027801. PubMed ID: 36892052
[TBL] [Abstract][Full Text] [Related]
91. Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer.
Thavendiranathan P; Shalmon T; Fan CS; Houbois C; Amir E; Thevakumaran Y; Somerset E; Malowany JM; Urzua-Fresno C; Yip P; McIntosh C; Sussman MS; Brezden-Masley C; Yan AT; Koch CA; Spiller N; Abdel-Qadir H; Power C; Hanneman K; Wintersperger BJ
JAMA Cardiol; 2023 Jun; 8(6):524-534. PubMed ID: 37043251
[TBL] [Abstract][Full Text] [Related]
92. Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma.
Meloni A; Gargani L; Bruni C; Cavallaro C; Gobbo M; D'Agostino A; D'Angelo G; Martini N; Grigioni F; Sinagra G; De Caterina R; Quaia E; Mavrogeni S; Cademartiri F; Matucci-Cerinic M; Pepe A
Int J Cardiol; 2023 Apr; 376():139-146. PubMed ID: 36731634
[TBL] [Abstract][Full Text] [Related]
93. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus.
Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM
Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323
[TBL] [Abstract][Full Text] [Related]
94. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
[TBL] [Abstract][Full Text] [Related]
95. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.
Ugander M; Oki AJ; Hsu LY; Kellman P; Greiser A; Aletras AH; Sibley CT; Chen MY; Bandettini WP; Arai AE
Eur Heart J; 2012 May; 33(10):1268-78. PubMed ID: 22279111
[TBL] [Abstract][Full Text] [Related]
96. Diagnostic Accuracy of Cardiovascular Magnetic Resonance for Cardiac Transplant Rejection: A Meta-Analysis.
Han D; Miller RJH; Otaki Y; Gransar H; Kransdorf E; Hamilton M; Kittelson M; Patel J; Kobashigawa JA; Thomson L; Berman D; Tamarappoo B
JACC Cardiovasc Imaging; 2021 Dec; 14(12):2337-2349. PubMed ID: 34274269
[TBL] [Abstract][Full Text] [Related]
97. Morphologic pattern of late gadolinium enhancement in Takotsubo cardiomyopathy detected by early cardiovascular magnetic resonance.
Avegliano G; Huguet M; Costabel JP; Ronderos R; Bijnens B; Kuschnir P; Thierer J; Tobón-Gomez C; Martinez GO; Frangi A
Clin Cardiol; 2011 Mar; 34(3):178-82. PubMed ID: 21400545
[TBL] [Abstract][Full Text] [Related]
98. Systematic review of cardiovascular magnetic resonance imaging T1 and T2 mapping in patients with Takotsubo syndrome.
Humayra S; Yahya N; Ning CJ; Mir IA; Mohamed AL; Manan HA
Heliyon; 2024 May; 10(9):e29755. PubMed ID: 38707280
[TBL] [Abstract][Full Text] [Related]
99. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
[TBL] [Abstract][Full Text] [Related]
100. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
